Computer vision is revolutionizing healthcare with AI-powered imaging, precise disease detection, and personalized treatments. Driven by rising demand for advanced diagnostics, growing AI adoption, and a projected CAGR of 35.19% through 2034, this market is shaping the future of medical innovation and patient outcomes
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Computer Vision in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Computer Vision in Healthcare Market, by Component
8.1.1 Software
8.1.1.1. Market Revenue and Forecast
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast
8.1.3. Cloud-based
8.1.3.1. Market Revenue and Forecast
8.1.4. Services
8.1.4.1. Market Revenue and Forecast
9.1. Computer Vision in Healthcare Market, by Application
9.1.1. Medical Image & Diagnosis
9.1.1.1. Market Revenue and Forecast
9.1.2. Surgical Assistance
9.1.2.1. Market Revenue and Forecast
9.1.3. Patient’s Identification
9.1.3.1. Market Revenue and Forecast
9.1.4. Remote Patient Monitoring
9.1.4.1. Market Revenue and Forecast
10.1. Computer Vision in Healthcare Market, by End-user
10.1.1. Hospital & Clinics
10.1.1.1. Market Revenue and Forecast
10.1.2. Diagnostics Centers
10.1.2.1. Market Revenue and Forecast
10.1.3. Academic Research Institutes
10.1.3.1. Market Revenue and Forecast
10.1.4. Other End-Users
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by End-user
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component
11.1.4.2. Market Revenue and Forecast, by Application
11.1.4.3. Market Revenue and Forecast, by End-user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by End-user
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by End-user
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component
11.2.4.2. Market Revenue and Forecast, by Application
11.2.4.3. Market Revenue and Forecast, by End-user
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by End-user
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by End-user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by End-user
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by End-user
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component
11.3.4.2. Market Revenue and Forecast, by Application
11.3.4.3. Market Revenue and Forecast, by End-user
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by End-user
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by End-user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by End-user
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by End-user
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component
11.4.4.2. Market Revenue and Forecast, by Application
11.4.4.3. Market Revenue and Forecast, by End-user
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component
11.4.5.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by End-user
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by End-user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component
11.4.7.2. Market Revenue and Forecast, by Application
11.4.7.3. Market Revenue and Forecast, by End-user
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component
11.5.2. Market Revenue and Forecast, by Application
11.5.3. Market Revenue and Forecast, by End-user
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component
11.5.4.2. Market Revenue and Forecast, by Application
11.5.4.3. Market Revenue and Forecast, by End-user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component
11.5.5.2. Market Revenue and Forecast, by Application
11.5.5.3. Market Revenue and Forecast, by End-user
12.1. AltexSoft
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AiCure
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Encord
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. on
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. InData Labs
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Insoftex
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NVIDIA Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Robovision BV.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shaip
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Softengi
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description